dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· February 12, 2026

OKX Ventures backs STBL in strategic partnership with Hamilton Lane and Securitize to launch RWA-backed stablecoin on X Layer

View original at globenewswire.com
OKX Ventures backs STBL in strategic partnership with Hamilton Lane and Securitize to launch RWA-backed stablecoin on X Layer DUBAI, United Arab Emirates and LONDON and CONSHOHOCKEN, Pa…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • RWA markets are entering a new phase, where tokenization must deliver real utility, not just representation. STBL provides a purpose-built architecture for RWA backed stablecoins combined with compliant yield management. Working with Hamilton Lane and OKX Ventures we are seeking to unlock deeper liquidity, yield management and efficient utility across onchain ecosystems.

    80% confidence
  • This structure shows how tokenization unlocks effective utility when it's paired with regulated issuance and programmable settlement. By embedding institutional private credit directly into onchain money flows, we're turning tokenized assets into functional building blocks: assets that can be settled, composed and used across financial applications, not just held.

    80% confidence
  • The collaboration strengthens the foundation for highly capital efficient RWA products across the network. Working with STBL and Hamilton Lane allows us to accelerate that mission and bring users a more mature RWA ecosystem.

    80% confidence

Cité dans ces articles de Via News

Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
OKX Ventures backs STBL in strategic partnership with Hamilton Lane and Securitize to launch RWA-backed stablecoin on X Layer: Source | Via News | fr.via.news